DS
IMVT icon

David Shaw’s Immunovant IMVT Stock Holding History

David Shaw’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8M Buy
+1,240,654
New +$37.8M 0.02% 788
2025
Q4 		– Sell
-56,700
Closed -$914K – 4788
2025
Q3 		$914K Sell
56,700
-3,118
-5% -$50.5K ﹤0.01% 3511
2025
Q2 		$957K Buy
59,818
+9,284
+18% +$140K ﹤0.01% 3259
2025
Q1 		$864K Sell
50,534
-17,135
-25% -$358K ﹤0.01% 3179
2024
Q4 		$1.68M Buy
67,669
+5,234
+8% +$148K ﹤0.01% 2858
2024
Q3 		$1.78M Buy
62,435
+20,956
+51% +$618K ﹤0.01% 2787
2024
Q2 		$1.1M Sell
41,479
-14,435
-26% -$411K ﹤0.01% 3140
2024
Q1 		$1.81M Sell
55,914
-52
-0.1% -$1.9K ﹤0.01% 2711
2023
Q4 		$2.36M Sell
55,966
-86,598
-61% -$3.19M ﹤0.01% 2538
2023
Q3 		$5.47M Sell
142,564
-620,647
-81% -$14M 0.01% 1735
2023
Q2 		$14.5M Buy
763,211
+318,758
+72% +$5.94M 0.01% 1078
2023
Q1 		$6.89M Buy
444,453
+145,983
+49% +$2.53M 0.01% 1676
2022
Q4 		$5.3M Buy
+298,470
New +$3.76M 0.01% 2042
2022
Q1 		– Sell
-20,371
Closed -$174K – 5721
2021
Q4 		$174K Buy
+20,371
New +$168K ﹤0.01% 4932
2021
Q2 		– Sell
-25,119
Closed -$403K – 4864
2021
Q1 		$403K Buy
+25,119
New +$662K ﹤0.01% 3599

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

David Shaw's IMVT Position: Q2 2026 in Review

David Shaw opened a new position in Immunovant (IMVT) in Q2 2026: 1,240,654 shares worth $47.8M. The stake represents 0.02% of the portfolio and ranks #788 among its holdings. This is a return to the name: David Shaw previously reported a position in IMVT as recently as Q3 2025.

David Shaw first reported a position in IMVT in Q1 2021 and has held it in 15 quarters since. 225 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • David Shaw held 1,240,654 shares of Immunovant worth $47.8M as of Q2 2026.
  • Immunovant was a new David Shaw position in Q2 2026.
  • Immunovant made up 0.02% of David Shaw's portfolio in Q2 2026, its #788 holding.
  • David Shaw first reported a position in Immunovant in Q1 2021 and has held it in 15 quarters since.
  • 225 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.